It does seem that there is a bit of unnecessary co
Post# of 148288
The WHO has tried to clarify this by establishing a mAb nomenclature scheme, involving prefixes, infixes and suffixes:
https://www.who.int/medicines/services/inn/Re...scheme.pdf
Perhaps it might also be helpful to simply distinguish between those that target antigen molecules vs cells and organs (e.g. analogous to antibodies vs auto-antibodies)
Auto-mAbs?